Picture of Lumibird SA logo

LBIRD — Lumibird SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Lumibird Q1 Revenue Down At 21.9 Million Euros

April 27 (Reuters) - LUMIBIRD SA  LBIRD.PA :
    * COVID-19 EPIDEMIC HAS ALSO IMPACTED REVENUES, BUT TO A
LIMITED
EXTENT, AS MAJORITY OF PRODUCT LINES ARE CONTINUING TO OPERATE
    * Q1 REVENUE EUR 21.9 MILLION VERSUS EUR 24.2 MILLION YEAR
AGO
    * END-MARCH FINANCIAL DEBT REPRESENTS EUR 36.6M
    * GROUP IS NOT CURRENTLY IN A POSITION TO FORECAST HOW
HEALTH
CRISIS WILL IMPACT REVENUES FOR YEAR
    * ORDER BOOK IS STILL ROBUST AND MAJORITY OF PRODUCTS ARE
CONTINUING TO BE SOLD
    * END-MARCH CASH, NET OF CURRENT BANK BORROWINGS, TOTALS EUR
48M,
AND FINANCIAL DEBT REPRESENTS EUR 36.6M
    * GROUP’S BUSINESS IS RUNNING MORE SLOWLY AS PRODUCTION
CAPACITY
IS BEING AFFECTED BY REDUCED STAFFING LEVELS FOR PRODUCTION THAN
UNDER NORMAL CONDITIONS
    * ON CORONAVIRUS: NEARLY 70% OF STAFF ARE OPERATIONAL
    * WILL CONTINUE TO FOCUS ON COMBINING ORGANIC AND EXTERNAL
GROWTH
IN THE THREE BUOYANT MARKETS (LIDAR, DEFENSE/SPACE AND MEDICAL)

Source text for Eikon:  ID:nBw4BTKfqa 
Further company coverage:  LBIRD.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Lumibird SA

See all news